Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

This study evaluated cross-resistance of Mycobacterium tuberculosis strains to ofloxacin, moxifloxacin, and gatifloxacin and investigated the presence of mutations in gyrA and gyrB. Fluoroquinolone susceptibilities were determined for 41 M. tuberculosis strains by the proportion method on 7H11, and MICs were determined by the resazurin microtiter assay. Forty strains shared the same resistance results for the three fluoroquinolones. However, one strain, with an Asn-533 --> Thr mutation in gyrB, was susceptible to ofloxacin but resistant to moxifloxacin and gatifloxacin.

Knowledge Graph

Similar Paper

Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
Antimicrobial Agents and Chemotherapy 2009.0
Are All the DNA Gyrase Mutations Found in Mycobacterium leprae Clinical Strains Involved in Resistance to Fluoroquinolones?
Antimicrobial Agents and Chemotherapy 2008.0
Molecular Analysis of the gyrA and gyrB Quinolone Resistance-Determining Regions of Fluoroquinolone-Resistant Clostridium difficile Mutants Selected In Vitro
Antimicrobial Agents and Chemotherapy 2009.0
Mutagenesis in the α3α4 GyrA Helix and in the Toprim Domain of GyrB Refines the Contribution of Mycobacterium tuberculosis DNA Gyrase to Intrinsic Resistance to Quinolones
Antimicrobial Agents and Chemotherapy 2008.0
Fluoroquinolone-Resistant Mutants ofBurkholderia cepacia
Antimicrobial Agents and Chemotherapy 2008.0
Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in Vietnam
Antimicrobial Agents and Chemotherapy 2009.0
Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in Taiwan
Antimicrobial Agents and Chemotherapy 2008.0
Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
In Vitro-Selected Linezolid-Resistant Mycobacterium tuberculosis Mutants
Antimicrobial Agents and Chemotherapy 2008.0
Sitafloxacin and Garenoxacin May Overcome the Antibiotic Resistance of Helicobacter pylori with gyrA Mutation
Antimicrobial Agents and Chemotherapy 2009.0